US Stock MarketDetailed Quotes

LIVN LivaNova

Watchlist
  • 52.520
  • +0.210+0.40%
Close Sep 27 16:00 ET
  • 52.520
  • 0.0000.00%
Post 16:03 ET
2.85BMarket Cap-169419P/E (TTM)

About LivaNova Company

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Company Profile

SymbolLIVN
Company NameLivaNova
Listing DateOct 19, 2015
Founded2015
CEOMr. Vladimir A. Makatsaria
MarketNASDAQ
Employees2900
Fiscal Year Ends12-31
Address20 Eastbourne Terrace
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW2 6LG
Phone44-203-325-0660

Company Executives

  • Name
  • Position
  • Salary
  • Vladimir A. Makatsaria
  • Chief Executive Officer and Director
  • --
  • Michael David Hutchinson
  • Senior Vice President, Chief Legal Officer and Corporate Secretary
  • 2.07M
  • Trui Hebbelinck
  • Chief Human Resources Officer
  • 1.78M
  • Alex Shvartsburg
  • Chief Financial Officer and Principal Accounting Officer
  • 2.77M
  • William A. Kozy
  • Chairman of the Board
  • 3.06M
  • Stephanie Bolton
  • President, Global Epilepsy
  • --
  • James Christopher Barry
  • Director
  • 117.88K
  • Todd C. Schermerhorn
  • Independent Director
  • 270.00K
  • Peter M. Wilver
  • Independent Director
  • 263.00K
  • Brooke Story
  • Independent Director
  • 248.00K
  • Dr. Sharon O'Kane
  • Lead Independent Director
  • 281.43K
  • Francesco Bianchi
  • Independent Director
  • 263.00K
  • Stacy Enxing Seng
  • Independent Director
  • 260.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data